ArticleBreast cancer research and treatment2022

HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome.

Faruk Skenderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.